SUBSEQUENT EVENTS	9 Months Ended
Sep. 30, 2015
Notes to Financial Statements
Note 8 - SUBSEQUENT EVENTS	On November 4, 2015, Dimitrios S. Goulielmos (the "Seller"), a resident of Greece and Chief Executive Officer and a director of Cosmos Holdings Inc. (the "Company"), entered into a Stock Purchase Agreement (the "SPA") with Grigorios Siokas (the "Buyer"), a resident of Greece. Pursuant to the SPA, the Seller has agreed to sell to the Buyer 95,000,000 of the 100,000,000 Common Shares of the Company owned by the Seller. The aggregate purchase price for the shares was $1.00; plus the obligation to repay various debt obligations of the Company, except with respect to the repayment of €200,000 Euro that was loaned by the Seller to Sky Pharm In addition, pursuant to the SPA, the Seller foregave and released the Company and Sky Pharm S.A., Amplerissimo Ltd. ("Sky Pharm"), the Company's subsidiary, from all claims; provided, that contingent upon the repayment of debt obligations, the Company will be forgiven and released from the $220,000 in loans to the Seller and the related accrued interest of $2,330. Sky Pharm will be forgiven and released from the €130,000 ($145,808) in loans to the Seller and the related accrued interest of €1,946 ($2,183).

SUBSEQUENT EVENTS

9 Months Ended

Sep. 30, 2015

On November 4, 2015, Dimitrios S. Goulielmos (the "Seller"), a resident of Greece and Chief Executive Officer and a director of Cosmos Holdings Inc. (the "Company"), entered into a Stock Purchase Agreement (the "SPA") with Grigorios Siokas (the "Buyer"), a resident of Greece. Pursuant to the SPA, the Seller has agreed to sell to the Buyer 95,000,000 of the 100,000,000 Common Shares of the Company owned by the Seller. The aggregate purchase price for the shares was $1.00; plus the obligation to repay various debt obligations of the Company, except with respect to the repayment of €200,000 Euro that was loaned by the Seller to Sky Pharm In addition, pursuant to the SPA, the Seller foregave and released the Company and Sky Pharm S.A., Amplerissimo Ltd. ("Sky Pharm"), the Company's subsidiary, from all claims; provided, that contingent upon the repayment of debt obligations, the Company will be forgiven and released from the $220,000 in loans to the Seller and the related accrued interest of $2,330. Sky Pharm will be forgiven and released from the €130,000 ($145,808) in loans to the Seller and the related accrued interest of €1,946 ($2,183).